Advanced APMs and the Emerging Role of Immuno-Oncology Agents: Balancing Innovation and Value
February 16th 2017The shift to value-based care, concurrent with innovations in immune-based care, will create challenges in oncology. What should be the physician and manufacturer responsibility during these changing times?